Hemenway Trust Co buys $3.3 Million stake in Danaher Corporation (DHR)

Danaher Corporation (DHR) : Hemenway Trust Co scooped up 20,650 additional shares in Danaher Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 27, 2016. The investment management firm now holds a total of 33,296 shares of Danaher Corporation which is valued at $3.3 Million.Danaher Corporation makes up approximately 0.89% of Hemenway Trust Co’s portfolio.

Other Hedge Funds, Including , Somerville Kurt F boosted its stake in DHR in the latest quarter, The investment management firm added 12,440 additional shares and now holds a total of 14,940 shares of Danaher Corporation which is valued at $1.5 Million. Danaher Corporation makes up approx 0.34% of Somerville Kurt F’s portfolio.Select Equity Group boosted its stake in DHR in the latest quarter, The investment management firm added 1,462,114 additional shares and now holds a total of 2,821,772 shares of Danaher Corporation which is valued at $278.6 Million. Danaher Corporation makes up approx 2.37% of Select Equity Group’s portfolio.Janus Capital Management boosted its stake in DHR in the latest quarter, The investment management firm added 244,776 additional shares and now holds a total of 554,719 shares of Danaher Corporation which is valued at $54.8 Million. Danaher Corporation makes up approx 0.05% of Janus Capital Management’s portfolio.Symphony Asset Management reduced its stake in DHR by selling 2,373 shares or 5.28% in the most recent quarter. The Hedge Fund company now holds 42,569 shares of DHR which is valued at $4.1 Million. Danaher Corporation makes up approx 0.80% of Symphony Asset Management’s portfolio. Aspiriant added DHR to its portfolio by purchasing 35,587 company shares during the most recent quarter which is valued at $3.5 Million. Danaher Corporation makes up approx 0.32% of Aspiriant’s portfolio.

Danaher Corporation opened for trading at $99.18 and hit $99.89 on the upside on Tuesday, eventually ending the session at $99.45, with a gain of 0.42% or 0.42 points. The heightened volatility saw the trading volume jump to 18,89,786 shares. Company has a market cap of $68,491 M.

On the company’s financial health, Danaher Corporation reported $1.08 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Apr 21, 2016. Analyst had a consensus of $1.03. The company had revenue of $5387.20 million for the quarter, compared to analysts expectations of $5329.83 million. The company’s revenue was up 14.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.93 EPS.

Many Wall Street Analysts have commented on Danaher Corporation. Company shares were Reiterated by RBC Capital Mkts on May 27, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 99 from a previous price target of $96 .Company shares were Reiterated by RBC Capital Mkts on Apr 22, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 96 from a previous price target of $87 .Company shares were Reiterated by Stifel on Apr 22, 2016 to “Buy”, Firm has raised the Price Target to $ 110 from a previous price target of $109 .

Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Company’s diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Company’s Industrial Technologies solutions help protect the world’s food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.

Leave a Reply

Danaher Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Danaher Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.